The Completely Endoscopic Treatment of Atrial Fibrillation: Report on the First 14 Patients with Early Results


  • Rawn Salenger
  • Stephen J. Lahey
  • Adam E Saltman



We report the early results of a new completely endoscopic technique for the treatment of atrial fibrillation (AF).

Methods: Fourteen patients underwent surgery solely for the treatment of AF. The thoracoscopic technique delivered microwave energy to the epicardial surface of the beating heart. Access was obtained through 3 right-sided and 3 left-sided thoracic ports. The AFx/Guidant Flex-10 catheter was employed to produce a box lesion around the pulmonary veins along with additional right- and left-sided lesions. The left atrial appendage was amputated.

Results: Ten patients had paroxysmal fibrillation, 1 had persistent fibrillation, and 3 were in permanent AF. Mean age of the group was 60 years, and their mean duration of AF was 74 months. Half had undergone unsuccessful attempts at chemical and/or electrical cardioversion. There were no deaths. Two patients required conversion to open procedure to control bleeding from the left atrial appendage. Average procedure time was 221 minutes, with the last 2 procedures taking less than 2 hours. Median length of hospital stay was 6 days, with 7 patients staying less than 3 days. Seventy-one percent of patients were in sinus rhythm at discharge, 100% at 6 months follow-up, and 67% at 12 months.

Conclusion: Totally endoscopic microwave ablation of atrial fibrillation appears to be safe and truly minimally invasive. It is associated with a short length of stay, short procedure time, and acceptable rhythm results. This procedure has the potential to greatly expand the indications for surgery in patients suffering from AF and deserves longer-term investigation.


Arcidi JM, Doty DB, Millar RC. 2000. The maze procedure: the LDS hospital experience. Semin Thorac Cardiovasc Surg 12:38-43.nMcCarthy PM, Gillinov AM, Castle L, et al. 2000. The Cox-maze procedure: the Cleveland Clinic experience. Semin Thorac Cardiovasc Surg 12:25-9.nRoy D, Talajic M, Dorian P, et al. 2000. Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 342;913-20.nSaltman AE, Rosenthal L, Francalancia NA, Lahey SJ. 2003. A completely endoscopic approach for ablation of atrial fibrillation. Heart Surgery Forum 6:2003-11333.nSchaff HV, Dearani JA, Daly RC, et al. 2000. Cox-Maze procedure for atrial fibrillation: Mayo Clinic experience. Semin Thorac Cardiovasc Surg 12:30-7.nShake JG, Larson DW, Kulick DM, et al. 2002. Transmural atrial insulating lesions using epicardially applied radiofrequency energy coupled with saline irrigation. J Invest Surg 15:101-7.nSie HT, Beukema WP, Ramdat Misier AR, et al. 2001. The radiofrequency modified maze procedure. A less invasive surgical approach to atrial fibrillation during open-heart surgery. Eur J Cardiothorac Surg 19:443-7.nSingh S, Zoble RG, Yellen L, et al. 2000. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study. Circulation 102:2385-90.nAtrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. 2002. A comparison of the control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825-33.nAutschbach R, Onnasch JF, Falk V, et al. 2000. The Leizpig experience with robotic valve surgery. J Card Surg 15:82-7.nCox JL, Ad N, Palazzo T, et al. 2000. Current status of the maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg 12:15-9.nDamiano RJ Jr, McCarthy PM, Gillinov AM, et al. 2003. Prospective multicenter clinical trial of surgical pulmonary vein isolation for the treatment of atrial fibrillation. J Am Coll Cardiol 41(suppl A):498A.nGillinov AM, Blackstone EH, McCarthy PM. 2002. Atrial fibrillation: current surgical options and their assessment. Ann Thorac Surg 74:2210-7.nKosakai Y. 2000. Treatment of atrial fibrillation using the maze procedure: the Japanese experience. Semin Thorac Cardiovasc Surg 12:44-52.nMazzitelli D, Park CH, Park KY, et al. 2002. Epicardial ablation of atrial fibrillation on the beating heart without cardiopulmonary bypass. Ann Thorac Surg 73:320-1.nThomas SP, Clout R, Deery C, et al. 1999. Microwave ablation of myocardial tissue: the effect of element design, tissue coupling, blood flow, power, and duration of exposure on lesion size. J Cardiovasc Electrophysiol. 10:72-8.nWatanabe H, Hayashi J, Sugawara M, et al. 1999. Experimental application of microwave tissue coagulation to ventricular myocardium. Ann Thorac Surg 67: 666-71.nWilliams MR, Knaut M, Berube D, Oz MC. 2002. Application of microwave energy in cardiac tissue ablation: from in vitro analyses to clinical use. Ann Thorac Surg 74:1500-5.n



How to Cite

Salenger, R., Lahey, S. J., & Saltman, A. E. (2005). The Completely Endoscopic Treatment of Atrial Fibrillation: Report on the First 14 Patients with Early Results. The Heart Surgery Forum, 7(6), E555-E558.